SUBSCRIBE
SUBSCRIBE
News   Business

Dowpharma Announces Multi-Product License Agreement with Merck & Co., Inc.

February 26, 2007 | 
1 min read
MIDLAND, MICH - February 22, 2007 -- Dowpharma today announced that Merck & Co., Inc. has entered into a multi-product commercial license agreement for Pfenex Expression Technology™, a Pseudomonas-based technology from Dowpharma.
Alliances
MORE ON THIS TOPIC
Collage image of people arms gloves hold equipment hit hammer cut saw nail gun isolated on creative white background.
Executive appointments
Merck Reorganizes Human Health Work Into Two New Units
February 23, 2026
 · 
1 min read
 · 
Annalee Armstrong
Concept of saving money with a pink colored piggy bank held in a hand in front of a blackboard with hand drawn coins
Weight loss
Novo’s CagriSema Falls to Lilly’s Zepbound in Daring Head-to-Head Test
February 23, 2026
 · 
4 min read
 · 
Annalee Armstrong
Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant
Layoff Tracker
BMS, Catalent Further Whittle Workforces
February 23, 2026
 · 
57 min read
 · 
BioSpace Editorial Staff
Insights
Redefining Obesity Treatment Beyond GLP-1 Limits
February 19, 2026
 · 
1 min read
 · 
Jennifer Smith-Parker